1st Quarter - Report

HOLLAND & KNIGHT LLP for PRAXAIR INC

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Energy/Nuclear ENG

Energy efficiency and related legislation; federal helium reserve.

LobbyistCovered position, as disclosed
JOHN BUSCHER —
RICHARD M GOLD —
KARL KOCH —
KATHRYN H LEHMAN —
BETH A VIOLA —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Budget/Appropriations BUD

Advocacy on Tonawanda - Army Corps of Engineers clean up.

LobbyistCovered position, as disclosed
RICHARD M GOLD —
DAVID HARRY MANN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Health Issues HCR

FDA regualtion of medical gas; H.R. 2227, Medical Gas Safety Act.

LobbyistCovered position, as disclosed
JIM DAVIS —
JOEL ROBERSON —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2227 (112th)

Taxation/Internal Revenue Code TAX

General international tax issues affecting U.S. based mulitnational coporations.

LobbyistCovered position, as disclosed
JIM DAVIS —
RICHARD M GOLD —
KATHRYN H LEHMAN —
PAOLO MASTRANGELO —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.